More leads. Better conversion. A new CRM. Another AI tool.
Each can be a sensible investment. None is a diagnosis.
When revenue disappoints, the visible symptom tends to attract the budget. A thin pipeline becomes a marketing project. Stalled deals become sales training. A weak forecast becomes a systems project. The difficulty is that the constraint may sit somewhere else.
The useful first question is: what is stopping the right customers from recognising, buying and realising the value we can offer?
Separate the observation from the explanation
“Deals take too long” is an observation. “Sales needs to follow up more” is one possible explanation.
Other explanations might include an unclear buying case, an offer aimed at the wrong segment, implementation effort the customer cannot absorb, or a decision process the seller has not understood. Those possibilities require different responses.
Start with a small set of comparable opportunities. Look at recent wins as well as losses and no-decisions. Record what happened, what the customer said, the alternative explanations and the evidence still missing.
The objective is a better decision about where to intervene.
Look across the commercial system
Seven questions provide a useful starting structure:
- Have we chosen the customers, markets and situations where we can win profitably?
- Do buyers understand a compelling reason to choose our offer?
- Are enough relevant opportunities reaching the commercial team?
- Can buyers progress through a clear decision and implementation process?
- Does the promised value become adoption, retention and further customer revenue?
- Do people, processes, data and tools allow the organisation to execute together?
- Where could AI change customer value, decisions or commercial workflows, with a credible business case?
A strong answer in one area does not compensate for a critical weakness elsewhere. More qualified demand has limited value if customers cannot implement the solution. Better automation will struggle to rescue an offer buyers do not value.
Choose a bounded starting engagement
If the uncertainty concerns priority customers, differentiation or the route to revenue, begin with a Revenue Engine Review.
If the commercial choices are coherent but relevant opportunities are scarce or inconsistent, a Pipeline & Demand Sprint can focus the acquisition and account-development work.
If buying friction, handoffs or unclear ownership prevent progress, a Commercial Execution Sprint can connect decisions to accountable delivery.
If the commercial foundations are reasonably clear but the AI opportunity remains unresolved, an AI Revenue Readiness & Value Review can establish the use case, readiness, economics and first test.
These are starting points. The evidence may change the initial hypothesis, and that is a useful result.
Make the first move small enough to learn from
Agree one priority, an owner, the evidence needed and a decision the work should enable. Choose measures that connect the intervention to customer value and commercial performance.
For example, an acquisition test should examine the fit and progression of opportunities, alongside their volume. A customer-success intervention should examine realised value and renewal or expansion, alongside activity. An AI test should establish the baseline, total effort and cost of exceptions before claiming a commercial gain.
The Blossomator Revenue Diagnostic is designed to prepare this conversation. Seven questions suggest a likely constraint and a relevant starting offer. Your answers remain in the page unless you choose to send them.
It is a starting hypothesis, not a validated diagnosis. The next step is to test it against your customers, your commercial evidence and the people who must make change happen.
← Back to insights